Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LLY
LLY logo

LLY News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LLY News

Eli Lilly Expands Coverage for Obesity Medications

2d agoPRnewswire

Eli Lilly's New Developments in GLP-1 Drugs

5h agoFool

Eli Lilly Faces Intensifying Competition in GLP-1 Drug Market

5h agoNASDAQ.COM

Is It Time to Reload Your Underinvested Portfolio?

7h agoFool

Analysis of Shopify's Stock Price Decline

7h agoNASDAQ.COM

Eli Lilly's Stock Surpasses $1,000, Potential Split Ahead

10h agoFool

Regulatory Approvals and Collaborations in Biotech Sector

1d agoNASDAQ.COM

Eli Lilly's Market Cap Surpasses $1 Trillion Again

1d agoYahoo Finance

LLY Events

05/28 07:00
Eli Lilly Announces Coverage of Obesity Drugs by Three Major PBMs
Eli Lilly (LLY) announced all three of the nation's largest pharmacy benefit managers, or PBMs, will cover Lilly's full obesity medicine portfolio. This significantly expands the number of Americans who can access FDA-approved options through their existing insurance. Lilly has worked across major PBMs to expand coverage for its obesity medicines. With today's news, coverage from CVS Caremark (CVS) Commercial Template begins June 1 for Foundayo. For current Zepbound patients, coverage continues uninterrupted, and access will broaden across template plans by October 1. For eligible patients with commercial coverage, both medicines are available for as little as $25 a month. Medicare Part D beneficiaries may also be eligible to pay $50 per month for their obesity medicines beginning July 1 through the Medicare GLP-1 Bridge program.
05/26 16:30
Major Averages Mixed as Eli Lilly and Others Engage in $4B Deals
The major averages had a mixed day back from the long weekend as markets reacted to reports of potential progress in U.S.–Iran talks aimed at ending the conflict. However, uncertainty remains as the president also warned that military action remains possible if talks fail and fresh clashes between the U.S. and Iran clouded the outlook for an interim deal to reopen the Strait of Hormuz. Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Eli LillyCurevo, LimmaTech Biologics, and Vaccine Company in deals worth up to $4B combinedBPsaid Albert Manifold has been removed as board chair followingAutoZonereportedChip stocks, including Micronand Qualcommrose on hopes that easing geopolitical tensions around the Iran conflict could reduce supply-chain and risk-premium pressuresFerrariunveiled, a five-seat electric vehicle2. WALL STREET CALLS:Marvellto Buy at HSBC on "undervalued" optical interconnect strengthBooz Allento Buy at StifelNorthlandIntel, Astera Labsand Semtechto Market PerformBofAthe firm's price target on Appleto $380 from $330UBSthe firm's price target on Micronto $1,625 from $5353. AROUND THE WEB:Occidental Petroleumis buying a 10% interest in Exxon Mobil'sdeepwater exploration block offshore Trinidad and Tobago, Reuters reportsThe European Union is set to open an in-depth investigation into Chinese e-commerce group JD.com'sbid for German electronics retailer Ceconomy, FT reportsWixis preparing its largest-ever round of layoffs, with plans to cut about 1,000 jobs, or roughly 20% of its workforce, following weak earnings, a sharp stock decline, and mounting pressure on profitability, Calcalist reportsPrologisand the American Bureau of Shipping will be anchoring a $200M venture-capital, VC, fund betting on a U.S. revival in maritime and logistics, WSJ saysNvidiaCEO Jensen Huang has asked Super Micro Computerto tighten its compliance after Taiwan detained three people for allegedly making fraudulent declarations related to AI servers made by Nvidia, Bloomberg says4. MOVERS:ASP Isotopesgains after announcing it hasthe first 18 stages of its Silicon-28 enrichment facility located in Pretoria, South AfricaOusterincreases after entering aSatellogichigher after securing an $18M contract forCircle Internetfalls after KeyBanccoverage of the stock with a Sector Weight ratingCosanlower in New York after HSBCthe stock to Reduce5. EARNINGS/GUIDANCE:VNET Groupand backed its guidance for FY26Champion Homes, with EPS and revenue beating consensusCSW Industrial, with CEO Jospeh Armes commenting, "I am pleased to report all-time record revenue and adjusted EBITDA for the fiscal Q4 and FY26"Uni-Fuelsand raised its guidance for FY26Dropboxand fiscal year 2026 financial results to be in-line with or above the guidance rangesINDEXES:The Dow fell 118.02, or 0.23%, to 50,461.68, the Nasdaq gained 312.21, or 1.19%, to 26,656.18, and the S&P 500 advanced 45.65, or 0.61%, to 7,519.12.
05/26 12:00
Major Averages Mixed at Noon as Markets React to U.S.-Iran Talks Progress
The major averages were mixed near noon as markets react to reports of potential progress in U.S.–Iran talks aimed at ending the conflict, with sentiment supported by President Trump's comments that negotiations were "proceeding nicely." However, uncertainty remains as the president also warned that military action remains possible if talks fail.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Eli LillyCurevo, LimmaTech Biologics, and Vaccine Company in deals worth up to $4B combinedBPsaid Albert Manifold has been removed as board chair followingAutoZonereportedChip stocks, including Micronand Qualcommare rising on hopes that easing geopolitical tensions around the Iran conflict could reduce supply-chain and risk-premium pressuresFerrariunveiled, a five-seat electric vehicle2. WALL STREET CALLS:Marvellto Buy at HSBC on "undervalued" optical interconnect strengthBooz Allento Buy at StifelNorthlandIntel, Astera Labsand Semtechto Market PerformBofAthe firm's price target on Appleto $380 from $330UBSthe firm's price target on Micronto $1,625 from $5353. AROUND THE WEB:Wixis preparing its largest-ever round of layoffs, with plans to cut about 1,000 jobs, or roughly 20% of its workforce, following weak earnings, a sharp stock decline, and mounting pressure on profitability, Calcalist reportsPrologisand the American Bureau of Shipping will be anchoring a $200M venture-capital, VC, fund betting on a U.S. revival in maritime and logistics, WSJ saysDelta Air Linestypically prides itself on not canceling flight, but recently, domestic-flight cancellation rates have been higher than industry average, WSJ reportsNvidiaCEO Jensen Huang has asked Super Micro Computerto tighten its compliance after Taiwan detained three people for allegedly making fraudulent declarations related to AI servers made by Nvidia, Bloomberg saysBHP Groupis pulling back on decarbonization projects in its Western Australian iron ore operations, Bloomberg reports4. MOVERS:ASP Isotopesgains after announcing it hasthe first 18 stages of its Silicon-28 enrichment facility located in Pretoria, South AfricaOusterincreases after entering awith ARGUS InterceptionSatellogichigher after securing anfor persistent earth observation monitoringCircle Internet (CRCL) falls after KeyBancof the stock with a Sector Weight ratingCosanlower in New York after HSBCthe stock to Reduce5. EARNINGS/GUIDANCE:VNET Groupand backed its guidance for FY26Champion Homeswith EPS and revenue beating consensusCSW Industrial, with CEO Jospeh Armes commenting, "I am pleased to report all-time record revenue and adjusted EBITDA for the fiscal Q4 and FY26"Uni-Fuelsand raised its guidance for FY26Dropboxand fiscal year 2026 financial results to be in-line with or above the guidance rangesINDEXES:Near midday, the Dow was down 0.25%, or 124.37, to 50,455.33, the Nasdaq was up 0.84%, or 220.48, to 26,564.45, and the S&P 500 was up 0.38%, or 28.40, to 7,501.87.

LLY Monitor News

Eli Lilly Expands Coverage for Obesity Medications

May 28 2026

Eli Lilly's Drug Trials Show Promising Weight Loss Results

May 13 2026

Eli Lilly and Roche Collaborate on Alzheimer's Blood Test

May 12 2026

Eli Lilly's Q1 Earnings Report Preview Highlights Strong Drug Sales

Apr 30 2026

Eli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion

Apr 24 2026

Eli Lilly's Foundayo Receives FDA Approval for Obesity Treatment

Apr 01 2026

Eli Lilly's EBGLYSS Shows Positive Results in Pediatric Eczema Trial

Mar 17 2026

Eli Lilly Launches Zepbound® KwikPen® to Improve Obesity Treatment Access

Mar 05 2026

LLY Earnings Analysis

Eli Lilly Q3 2025 Earnings: Revenue Growth & Strategic Gains- Intellectia AI™
7 months ago
Eli Lilly Q2 2025 Earnings: Record Growth & Future Prospects- Intellectia AI™
9 months ago
Eli Lilly's Triumph in Q4 2024 - Intellectia AI™
1 years ago
Eli Lilly and Company Reports Third Quarter 2024 Financial Results
1 years ago

People Also Watch